Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-10-07

Clinical Trial Update: Exploratory Study of the Expression of the Serotonergic 5-HT4 Receptor in Parkinson's Disease [NA]

View source ↗

Summary

An exploratory study assessing expression of the serotonin 5-HT4 receptor in Parkinson's disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Hospices Civils de Lyon | Conditions: Parkinson Disease | NA | Status: COMPLETED